ストックスクリーナーアプリを入手
3.17
3.35%
-0.11
前日終値:
$3.28
開ける：
$3.245
24時間の取引高:
22,528
Relative Volume:
11.92
時価総額：
$7.97M
収益：
$7.15M
当期純損益:
$4.03M
株価収益率:
-0.587
EPS:
-5.4
ネットキャッシュフロー:
$-11.33M
1週間 パフォーマンス:
-58.23%
1か月 パフォーマンス:
-58.23%
6か月 パフォーマンス:
-58.23%
1年 パフォーマンス:
-58.23%
1日の値動き範囲:
$3.05
$3.31
1週間の範囲:
$2.97
$3.75
52週間の値動き範囲:
$2.97
$3.75
Trxade Health Inc Stock (MEDS) Company Profile
Compare MEDS vs HITI, PETS, SCNX, POM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MEDS
Trxade Health Inc
|
3.17 | 7.97M | 7.15M | 4.03M | -11.33M | -5.40 |
HITI
High Tide Inc
|
2.15 | 188.92M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.99 | 42.53M | 179.02M | -57.29M | -33.01M | -2.7487 |
SCNX
Scienture Holdings Inc
|
0.3693 | 15.00M | 656.60K | -16.79M | -11.12M | -1.0743 |
POM
Pomdoctor Ltd Adr
|
0.7101 | 5.29M | 0 | 0 | 0 | 0.00 |
Trxade Health Inc (MEDS) 最新ニュース
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. - Stock Titan
SCNXScienture Holdings Inc Stock Price and Quote - Finviz
Trxade Health announces name change to Scienture Holdings - Intellectia AI
MEDS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Intellectia AI
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - Intellectia AI
MEDS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
MEDS News & Events - Intellectia AI
MEDSTRxADE HEALTH, Inc. Latest Stock News & Market Updates - Stock Titan
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Quantisnow
SCIENTURE Appoint Dr. Shankar Hariharan and Dr. Narasimhan Mani as Co-CEO’s - citybiz
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC - ACCESS Newswire
TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC. - ACCESS Newswire
Wellgistics Health (MEDS) Stock Price, News & Analysis - Stock Titan
Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model - ACCESS Newswire
Oragenics Appoints Janet Huffman As Interim CEO - citybiz
Urgent Company Parent Co. Sued By Eat Well Investment Group - Nosh.com
Group Alleges $10M 'Sham' In Fla. Plant-Based Co. Stock Deal - Law360
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
MEDS Price History for Trxade Health Stock - Barchart.com
Trxade Health (MEDS) Q2 2024 Research Summary - AlphaStreet
About Us - FinancialContent
Dykema Guides TRxADE in Another Acquisition - Dykema
Tampa pharma company stacked with former McKesson execs launches IPO - The Business Journals
TRxADE HEALTH (MEDS) Stock News & Updates - Stock Titan
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
TRxADE Health, Inc. Announces Special Cash Dividend - Stock Titan
Why Is Trxade Health (MEDS) Stock Up 230% Today? - InvestorPlace
Dykema Completes Sale of Assets for TRxADE Health, Inc. - Dykema
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results - AlphaStreet
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry. - Yahoo Finance
Food technology company prepares to enter plant-based pet nutrition market - Pet Food Processing
Trxade Health (MEDS) Stock Is Moving Higher: What's Going On? - Benzinga
Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary - AlphaStreet
Artemis Strategic (ARTE) to Combine with Danam Health in $200M Deal - SPACInsider
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc. - GlobeNewswire
Trxade Health up 68%this time it’s a real price movement on a reverse takeover - Dhaka Tribune
Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to Create a Global Food Consolidation Platform - GlobeNewswire
Trxade Health, MEDS, is up 1,506% or 7%, take your pick - Dhaka Tribune
TRxADE HEALTH, Inc. (NASDAQ:MEDS) Q1 2023 Earnings Call Transcript - Insider Monkey
MEDS Earnings: Trxade Health’s net loss narrows in Q1 2023; revenue down 31% - AlphaStreet
Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu - AlphaStreet
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows - AlphaStreet
Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary - AlphaStreet
Trxade explores alternative ways to find partners for B2C assets: CEO Suren Ajjarapu - AlphaStreet
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows - AlphaStreet
Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups - Yahoo Finance
Trxade Health, Inc. Appoints Mr. Jeff Newell to Its Board of Directors, Member of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee - marketscreener.com
TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus Program - Yahoo Finance
TRxADE HEALTH Announces Termination of Public Offering of Common Stock - Yahoo Finance
MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth - AlphaStreet
Trxade Health Inc (MEDS) 財務データ
収益
当期純利益
現金流量
EPS
0.56%
0.00%
大文字化:
|
ボリューム (24 時間):